TRAP1 and leukemia: Although prior work has identified TRAP1 (Bryant et al., 2017; Ramkumar et al., 2020) as a potential anticancer target in leukemia, genetic knockdown in MV-4–11 cells increased, rather than decreased, cellular proliferation in the present study.